| Name | Protein Cripto | ||
| UniProt ID | TDGF1_HUMAN | ||
| Gene Name | CRIPTO | ||
| Gene ID | 6997 | ||
| Synonyms |
CRIPTO, CR, CR-1, CRGF, TDGF1
|
||
| Sequence |
MDCRKMARFSYSVIWIMAISKVFELGLVAGLGHQEFARPSRGYLAFRDDSIWPQEEPAIR
PRSSQRVPPMGIQHSKELNRTCCLNGGTCMLGSFCACPPSFYGRNCEHDVRKENCGSVPH DTWLPKKCSLCKCWHGQLRCFPQAFLPGCDGLVMDEHLVASRTPELPPSARTTTFMLVGI CLSIQSYY |
||
| Pathway Map | MAP LINK | ||
| T.C. Number | 1.A.10.1.28; 3.A.1.201.1 | ||
| KEGG ID | hsa6997 | ||
| TTD ID | T47864 | ||
| Pfam | PF00008; PF07974; PF09443; PF12661 | ||
| Pair Name | Luteolin, Paclitaxel | |||
| Phytochemical | Luteolin | |||
| Drug | Paclitaxel | |||
| Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
| Regulate Info | Down-regulation | Protein Cripto | Expression | |
| Result | These findings suggest that luteolin treatment significantly attenuated the hallmarks of breast cancer stemness by downregulating Nrf2-mediated expressions. Luteolin constitutes a potential agent for use in cancer stemness-targeted breast cancer treatments. | |||
